Direktorat Registrasi ObatValid

FEBUXOSTAT

BPOM Number: GKL2605070117B1
Approved: 17 May 2026
Expiry: 2 May 2031
Form: TABLET SALUT SELAPUT

About This Registration

FEBUXOSTAT is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2605070117B1. Its current registration status is Valid, with the licence valid until 2 May 2031. The product is registered to DEXA MEDICA - INDONESIA. BPOM first approved this registration in May 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: newaero
Packaging: DUS, 3 STRIP @ 10 TABLET SALUT SELAPUT
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

DEXA MEDICA - INDONESIA
KOTA PALEMBANG
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

DEXA MEDICA - INDONESIA
KOTA PALEMBANG
primary
View profile →

Ingredients (1)

FEBUXOSTAT

Market Intelligence

Owner Portfolio: DEXA MEDICA - INDONESIA holds 528 BPOM registrations
Manufacturer Scale: DEXA MEDICA - INDONESIA produces 528 registered products
Registration Age: Registered for 2 months
Update Status: Recently updated (61 days ago)